Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Mandjes, IAM"'
Autor:
Nederlof I; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Isaeva OI; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Graaf M; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Gielen RCAM; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bakker NAM; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rolfes AL; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Garner H; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Boeckx B; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Traets JJH; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Maaker M; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Brussel T; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Chelushkin M; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Champanhet E; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van de Vijver K; Department of Pathology, UZ Gent - Universitair Ziekenhuis Gent, Gent, Belgium.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van den Berg JG; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hofland I; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Klioueva N; Department of Pathology, OLVG Hospital, Amsterdam, the Netherlands., Mann RM; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Loo CE; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Duijnhoven FH; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Skinner V; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Luykx S; Medical Oncology Department, Tergooi Hospital - locatie Hilversum, Hilversum, the Netherlands., Kerver E; Department of Oncology, OLVG Hospital, Amsterdam, the Netherlands., Kalashnikova E; Natera, San Carlos, CA, USA., van Dongen MGJ; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Blank CU; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Visser KE; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Salgado R; Department of Pathology, ZAS hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Drukker CA; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Kok M; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.
Publikováno v:
Nature medicine [Nat Med] 2024 Nov; Vol. 30 (11), pp. 3223-3235. Date of Electronic Publication: 2024 Sep 16.
Autor:
Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum AGJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoogstraat M; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bounova G; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Biometrics department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Data center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, the Netherlands., Canisius S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Biometrics department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, the Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bos MEMM; Department of Internal Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Bakker S; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kester L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rutgers EJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Menezes RX; Biostatistics Centre, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands., Kok M; Division of Tumor biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center, Utrecht, the Netherlands.
Publikováno v:
IScience [iScience] 2024 Jun 29; Vol. 27 (8), pp. 110425. Date of Electronic Publication: 2024 Jun 29 (Print Publication: 2024).
Autor:
Geurts VCM; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Voorwerk L; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Balduzzi S; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Salgado R; Department of Pathology, ZAS, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia., Van de Vijver K; Department of Pathology, University Hospital Ghent, Cancer Research Institute Ghent (CRIG), Ghent, Belgium., van Dongen MGJ; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Heuver M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Sparreboom W; Astra Zeneca, The Hague, the Netherlands., Haanen JBAG; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: M.Kok@nki.nl.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2023 Aug; Vol. 70, pp. 76-81. Date of Electronic Publication: 2023 Jun 27.
Autor:
Voorwerk L; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Isaeva OI; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Balduzzi S; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Chelushkin M; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bakker NAM; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Champanhet E; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Garner H; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Loo CE; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Maaker M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Boers J; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., de Boer M; Department of Medical Oncology, GROW, Maastricht University Medical Center, Maastricht, the Netherlands., Salgado R; Department of Pathology, GZA-ZNA hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., van Dongen MGJ; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Visser KE; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Schumacher TN; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Blank CU; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Jager A; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW, Maastricht University Medical Center, Maastricht, the Netherlands., Schröder CP; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Kok M; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.
Publikováno v:
Nature cancer [Nat Cancer] 2023 Apr; Vol. 4 (4), pp. 535-549. Date of Electronic Publication: 2023 Apr 10.
Autor:
Kester L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-Hubrecht Institute- KNAW & University Medical Centre Utrecht, Utrecht, the Netherlands., Seinstra D; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum AGJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Vennin C; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoogstraat M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Velden D; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hahn K; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof I; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Data Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, the Netherlands., Canisius S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, the Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bos MEMM; Department of Internal Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Bakker SD; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands., Rutgers EJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Voest EE; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, Den Haag, the Netherlands., van Oudenaarden A; Oncode Institute-Hubrecht Institute- KNAW & University Medical Centre Utrecht, Utrecht, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center, Utrecht, the Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Molecular Cancer Research, Center Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 01; Vol. 28 (5), pp. 960-971.
Autor:
van Rossum AGJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Mandjes IAM; Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Tinteren H; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Nederlof P; Department of Molecular Diagnostics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Alphen RJ; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Platte E; Clinical Chemical Laboratory, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek D; Clinical Chemical Laboratory, Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema A; Pharmacy, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center, Utrecht, The Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands.
Publikováno v:
Breast care (Basel, Switzerland) [Breast Care (Basel)] 2021 Dec; Vol. 16 (6), pp. 598-606. Date of Electronic Publication: 2021 Jan 22.
Autor:
Joosten SEP; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wellenstein M; WSK Medical B.V, Amsterdam, The Netherlands., Koornstra R; Department of Internal Medicine and Medical Oncology, Rijnstate hospital, Arnhem, The Netherlands., van Rossum A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Noort V; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ferrandez MC; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Harkes R; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mandjes IAM; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema A; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Wesseling J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van Diest PJ; Department of Pathology, University Medical Centre, Utrecht, The Netherlands., Horlings HM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.horlings@nki.nl., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Pathology, University Medical Centre, Utrecht, The Netherlands. s.linn@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.zwart@nki.nl.; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. w.zwart@nki.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2021 Oct 20; Vol. 7 (1), pp. 138. Date of Electronic Publication: 2021 Oct 20.
Autor:
Kozar, Nejc1,2, Lovrec, Vida Gavrić1,2
Publikováno v:
European Journal of Gynaecological Oncology. Dec2024, Vol. 45 Issue 6, p150-156. 7p.
Autor:
Baird RD; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom. rdb39@cam.ac.uk., van Rossum AGJ; Netherlands Cancer Institute, Amsterdam, the Netherlands., Oliveira M; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Beelen K; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Reinier de Graaf Gasthuis, Delft, the Netherlands., Gao M; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Schrier M; Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Netherlands Cancer Institute, Amsterdam, the Netherlands., Garcia-Corbacho J; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Vallier AL; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Dougall G; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., van Werkhoven E; Netherlands Cancer Institute, Amsterdam, the Netherlands., Linossi C; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Kumar S; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., van Tinteren H; Netherlands Cancer Institute, Amsterdam, the Netherlands., Callari M; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Beddowes E; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Perez-Garcia JM; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain., Rosing H; Netherlands Cancer Institute, Amsterdam, the Netherlands., Platte E; Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof P; Netherlands Cancer Institute, Amsterdam, the Netherlands., Schot M; Netherlands Cancer Institute, Amsterdam, the Netherlands., de Vries Schultink A; Netherlands Cancer Institute, Amsterdam, the Netherlands., Bernards R; Netherlands Cancer Institute, Amsterdam, the Netherlands., Saura C; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Gallagher W; University College Dublin, Dublin, Ireland., Cortès J; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain., Caldas C; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Linn SC; Netherlands Cancer Institute, Amsterdam, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Nov 15; Vol. 25 (22), pp. 6598-6605. Date of Electronic Publication: 2019 Aug 22.
Autor:
Voorwerk L; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Slagter M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van de Vijver KK; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Ghent University Hospital, Ghent, Belgium., de Maaker M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof I; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kluin RJC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Warren S; NanoString Technologies, Inc, Seattle, WA, USA., Ong S; NanoString Technologies, Inc, Seattle, WA, USA., Wiersma TG; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Russell NS; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lalezari F; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schouten PC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bakker NAM; Oncode Institute, Utrecht, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ketelaars SLC; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Peters D; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lange CAH; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Onderwater S; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Chalabi M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wilgenhof S; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JBAG; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Salgado R; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia., de Visser KE; Oncode Institute, Utrecht, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Blank CU; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.
Publikováno v:
Nature medicine [Nat Med] 2019 Jul; Vol. 25 (7), pp. 1175.